FORESEE PHARMACEUTICALS, INC. Employee Directory
Pharmaceutical ManufacturingDelaware, United States11-50 Employees
Foresee Pharmaceuticals, Inc. is a small pharmaceutical manufacturing company based in Newark, Delaware. It focuses on long-acting injectable therapies and related platform technology, building on its first SIF-derived product Camcevi. In October 2023, the firm launched the Casppian Phase 3 registration study, marking a notable clinical program within its portfolio. Recent developments include a positive CHMP opinion for Camcevi 21 mg in the EU as of March 2026. The company also engages with the scientific community through appearances and participation at major conferences in 2025, including the American Thoracic Society International Conference and the ASCO Genitourinary Cancers Symposium. Further information about the company is available on its website at foreseepharma.com.